课题基金 / 基金详情

Structural diversity of mucins : Significance in infection and immunity

Structural diversity of mucins : Significance in infection and immunity
粘蛋白的结构多样性:在感染和免疫中的意义
批准号:
12307054
负责人:
IRIMURA Tatsuro
金额:
$27.58万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2003

项目摘要

项目成果

IRIMURA Tatsuro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The specific aim of this proposal was to prove or disprove a hypothesis whether mucins, epithelial surface glycoproteins with a high degree of O-glycosylation, played roles as specific defense molecules against parasites, such as protozoa, bacteria, and viruses. The following conclusions were obtained.(1)Epithelial mucins were highly diverse in their glycosylation profiles.(2)The specific glycosylation of mucins were regulated in a high degree of fidelity by concerted actions of multiple UDP-GalNAc-polypeptide N-acetylgalactosaminyltransferases (ppGalNAc Ts).(3)A Th2 cytokine, IL-4, drastically enhance the expression of a few ppGalNAc Ts (ppGalNAc T1, 4, and 7), which resulted in an alteration of glycosylation profiles of mucin 2.(4)After such alterations, the secreted mucins changed its reactivity with lectins, carbohydrate-binding proteins.(5)Various oligosaccharide-polypeptide complexes were prepared by the use of recombinant ppGalNAc Ts and other glycosyltransferases in vitro. They were tested to determine the specificity of lectins toward mucin motifs.(6)Variations in mucin motifs on pathogens, such as the surface coat glycoproteins of Ebola virus, were also shown to play important roles in the regulation of infective processes.(7)In these processes, C-type/galactose-type lectins on macrophages and dendritic cells were shown to be significantly involved.
期刊论文(65)
专著(0)
科研奖励(0)
会议论文
Miyahara N, Shoda J, Kawamoto T, Furukawa M, Ueda T, Todoroki T, Tanaka N, Matsuo K, Yamada Y, Kohno K, Irimura T.: "Expression of UDP-N Acetylgalactosaminyl transferase isozyme 3 in the subserosal layer correlates with postsurgical survival of pathologic
Miyahara N、Shoda J、Kawamoto T、Furukawa M、Ueda T、Todoroki T、Tanaka N、Matsuo K、Yamada Y、Kohno K、Irimura T.:“浆膜下层中 UDP-N 乙酰半乳糖胺基转移酶同工酶 3 的表达与
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Horinouchi M, Nagata K, Nakamura A, Goto M, Takao S, Sakamoto M, Fukushima N, Miwa A, Irimura T, Imai K, Sato E, Yonezawa S.: "Expression of Different Glycoforms of Membrane Mucin (MUC1) and Secretory Mucin (MUC2, MUCSAC and MUC6) in Pancreatic Neoplasms.
Horinouchi M、Nagata K、Nakamura A、Goto M、Takao S、Sakamoto M、Fukushima N、Miwa A、Irimura T、Imai K、Sato E、Yonezawa S.:“膜粘蛋白(MUC1)和分泌物的不同糖型的表达
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Bando T: "Basic studies on a labeled anti-mucin antibody detectable by infrared-fluorescence endoscopy"J Gastroenterol.. 37. 260-269 (2002)
Bando T:“可通过红外荧光内窥镜检测的标记抗粘蛋白抗体的基础研究”J Gastroenterol.. 37. 260-269 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Onami TM: "The generation of mice deficient for the macrophage galactose and N-acetylgalactosamine specific lectin : limited role in lymphoid and erythroid homeostasis, and evidence for multiple lectins"Mol Cell Biol.. 22. 5173-5181 (2002)
Onami TM:“巨噬细胞半乳糖和 N-乙酰半乳糖胺特异性凝集素缺陷的小鼠的产生:在淋巴和红细胞稳态中的有限作用,以及多种凝集素的证据”Mol Cell Biol.. 22. 5173-5181 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
61
    Development of cancer stem cells driven by microenvironment
    MUC21 glycoforms as the target of cancer diagnosis and therapy
    Regulation of IgA responses against influenza virus
    A peptide sequence motif which regulates glycoforms
    • 批准号:
      22659016
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.98万
    • 财政年份:
      2010
    • 负责人:
      IRIMURA Tatsuro
    • 依托单位:
    国内基金
    海外基金
    Red/ET重组BCAS1工程菌的构建及通过MUC2调控缓解仔猪腹泻的机制研究
    • 批准号:
      2026JJ70027
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      王雁灿
    • 依托单位:
    辐射诱导肠道杯状细胞内质网应激调控黏蛋白MUC2分泌的作用机制研究
    • 批准号:
      --
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      谢黎伟
    • 依托单位:
    苦燥湿药性理论下善连丸调节苦味受体介导MUC2唾液酸化重塑UC肠黏液屏障作用的机制研究
    巯基介导的花色苷/豌豆白蛋白递送体系与肠道粘蛋白MUC2的粘附作用机制研究
    • 批准号:
      32372360
    • 项目类别:
      面上项目
    • 资助金额:
      50万元
    • 批准年份:
      2023
    • 负责人:
      季俊夫
    • 依托单位: